Metastatic properties of prostate cancer cells are controlled by VEGF. (Q40500872)

21 September 2017

Metastatic properties of prostate cancer cells are controlled by VEGF. (English)

1 reference

21 September 2017

Juhua Chen

1

1 reference

21 September 2017

Sarmishtha De

series ordinal

2

1 reference

21 September 2017

Jennifer Brainard

series ordinal

3

1 reference

21 September 2017

Tatiana V Byzova

series ordinal

4

1 reference

21 September 2017

1 January 2004

1 reference

Cell Communication & Adhesion

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

1

1 reference

21 September 2017

1-11

1 reference

Beta 1 integrin is essential for teratoma growth and angiogenesis

21 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Mechanisms governing bone metastasis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Molecular pathway for cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Expression of vascular endothelial growth factor receptors in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Antiangiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Integrins: versatility, modulation, and signaling in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Adhesion molecules in cancer: the role of integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Ligand binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Role of integrins in the attachment of metastatic follicular thyroid carcinoma cell lines to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Targeting angiogenic pathways involving tumor-stromal interaction to treat advanced human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Integrin signaling and matrix assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15419060490471739

10.1080/15419060490471739

21 January 2018

Identifiers

DOI

1 reference

release_u6dv4ets6fgxhfvklpjfqo77yu

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u6dv4ets6fgxhfvklpjfqo77yu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference